RecallRadar

FDA Drug recall D-0499-2019

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag,…

On 2019-02-27 the FDA classified a Class III recall of Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag,… by Advanced Pharma, citing superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0499-2019
ClassificationClass III
Statusterminated
Initiated2019-02-06
Published2019-02-27
Last updated2026-09-13 11:52 UTC
CompanyAdvanced Pharma
DistributionUS

Product

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

Reason

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Identifiers

code_infoLots: 11/27/18 3177 70650P, BUD: 02/10/2019; 11/27/18 6618 70650P, BUD: 02/10/2019; 11/28/18 7716 70650P, BUD: 02/12/19; 12/31/18 5698 70650P, BUD: 03/16/19

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0499-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.